AROC.NYSEArchrock, INC

Form 4: Archrock Director Hall Receives Equity Grant

Sentiment:

Insider Transaction Report


Archrock, Inc. Director Gordon T. Hall was granted 5,313 shares of restricted common stock, vesting over 2026.

Summary

  • Director Gordon T. Hall acquired 5,313 shares of Archrock, Inc. common stock.
  • The acquisition was a grant of restricted stock under the Archrock, Inc. 2020 Stock Incentive Plan.
  • The shares will vest in four equal installments: 25% on January 29, 2026 (date of grant), June 1, 2026, September 1, 2026, and December 1, 2026.
  • Following this transaction, Mr. Hall beneficially owns 242,251 shares of common stock.
  • The grant price per share was $0.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, as it aligns director incentives with shareholder interests through equity ownership, a standard and healthy corporate governance practice.

Positives

  • The equity grant aligns the director's interests with those of shareholders, incentivizing long-term performance.
  • The grant is part of the company's 2020 Stock Incentive Plan, indicating a structured approach to executive and director compensation.

Negatives

  • No negative aspects are directly indicated by this routine insider transaction filing.

Risks

  • The award is subject to forfeiture or accelerated vesting based on certain events outlined in the Award Notice and Agreement, introducing a degree of uncertainty regarding the final number of shares retained.

Future Outlook

The restricted stock grant is subject to a vesting schedule, with 25% vesting on the grant date and subsequent 25% tranches vesting on June 1, September 1, and December 1, 2026, indicating future equity accumulation for the director.

Industry Context

StockSavvy.ai notes that equity grants to directors are a standard practice across industries, particularly in the energy sector, to align leadership incentives with long-term shareholder value. This grant to an Archrock director is consistent with typical corporate governance practices for publicly traded companies.

Comparison to Industry Standards

  • Equity grants to directors are a common compensation component, often used by companies like Kinder Morgan (KMI) or Energy Transfer (ET) to incentivize long-term commitment and performance.
  • The vesting schedule, with tranches over a year, is a standard approach to retain directors and ensure continued engagement, similar to practices seen at peer companies in the midstream energy infrastructure space.
  • The grant of restricted stock at a $0 price is typical for incentive awards, differentiating it from stock options which usually have an exercise price.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Power of Attorney GrantDirector Gordon T. Hall granted a Power of Attorney to Stephanie C. Hildebrandt, Andrew Gratz, and William P. Bowes, Jr. to execute Forms 3, 4, and 5 on his behalf for Section 16(a) compliance.04/24/2025Streamlines insider trading reporting for the director, ensuring timely and accurate SEC filings.

Stakeholder Impact

  • **Shareholders:** The equity grant aligns the director's financial interests with long-term shareholder value creation, potentially leading to more shareholder-friendly decisions. However, it also represents a minor dilution of existing shares.
  • **Management/Employees:** The grant reinforces the company's compensation structure for leadership, potentially boosting morale and retention among key personnel.

Next Steps

  • The remaining 75% of the restricted stock grant will vest in three equal installments on June 1, 2026, September 1, 2026, and December 1, 2026.
  • The director will continue to hold the beneficially owned shares, subject to the terms of the restricted stock agreement.

Key Dates

DateDescription
04/24/2025Effective date of Power of Attorney granted by Gordon T. Hall.
01/29/2026Date of restricted stock grant and first vesting tranche (25%).
02/02/2026Signature date of the Form 4 filing by attorney-in-fact.
06/01/2026Second vesting tranche (25%) of restricted stock.
09/01/2026Third vesting tranche (25%) of restricted stock.
12/01/2026Fourth and final vesting tranche (25%) of restricted stock.

Keywords

Archrock, AROC, Gordon T Hall, Restricted Stock, Equity Grant, Insider Transaction, Form 4, Director Compensation, Stock Incentive Plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.